ChatGPT will see you now. Artificial intelligence isn't quite that ubiquitous yet in hospitals or biopharma labs. Chatbots from OpenAI, Anthropic and Alphabet (GOOGL) aren't actively diagnosing diseases or helping develop medicines. But that sci-fi scenario might not be far out of reach. The biggest names behind biotech stocks are investing heavily in AI, hoping they can speed up the decades-long process of developing lifesaving drugs, and cut down on the billions of dollars required to do it.

ID: 7133